Viewing Study NCT06271512


Ignite Creation Date: 2025-12-26 @ 11:13 PM
Ignite Modification Date: 2026-03-14 @ 7:14 AM
Study NCT ID: NCT06271512
Status: RECRUITING
Last Update Posted: 2025-02-11
First Post: 2024-02-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Participants with Β-Thalassemia Treated with Betibeglogene Autotemcel
Sponsor: Genetix Biotherapeutics Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: REG-501
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NETWORK View